@article{damaj_g_upfront_2014,
title = {Upfront Allogeneic Stem Cell Transplantation after Reduced-Intensity/Nonmyeloablative Conditioning for Patients with Myelodysplastic Syndrome: A Study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire},
volume = {20},
issn = {1083-8791},
url = {http://www.ncbi.nlm.nih.gov/pubmed/24838178},
DOI = {10.1016/j.bbmt.2014.05.010},
Language = {English},
Journal = {Biol. Blood Marrow Transplant.},
author = {{Damaj G} and {Mohty M} and {Robin M} and {Michallet M} and {Chevallier P} and {Beguin Y} and {Nguyen S} and {Bodes P} and {Blaise D} and {Maillard N} and {Rubio MT} and {Fegueux N} and {Cornillon J} and {Clavert A} and {Huynh A} and {Ades L} and {Thiebaut-Bertrand A} and {Hermine O} and {Vigouroux S} and {Fenaux P} and {Duhamel A} and {Yakoub-Agha I}},
year = {2014},
keywords = {Adult, Aged, Antimetabolites, Antineoplastic/therapeutic use*, Azacitidine/therapeutic use*, Female, Hematopoietic Stem Cell Transplantation/methods*, Humans, Male, Middle Aged, Myelodysplastic Syndromes/mortality, Myelodysplastic Syndromes/therapy*, Transplantation Conditioning/methods*, Transplantation, Homologous/methods*, Young Adult},
pages = {1349-1355}
}

{"_id":"My55FG6mceueMan4Z","bibbaseid":"damajg-mohtym-robinm-michalletm-chevallierp-beguiny-nguyens-bodesp-etal-upfrontallogeneicstemcelltransplantationafterreducedintensitynonmyeloablativeconditioningforpatientswithmyelodysplasticsyndromeastudybythesocietefrancaisedegreffedemoelleetdetherapiecellulaire-2014","authorIDs":[],"author_short":["Damaj G","Mohty M","Robin M","Michallet M","Chevallier P","Beguin Y","Nguyen S","Bodes P","Blaise D","Maillard N","Rubio MT","Fegueux N","Cornillon J","Clavert A","Huynh A","Ades L","Thiebaut-Bertrand A","Hermine O","Vigouroux S","Fenaux P","Duhamel A","Yakoub-Agha I"],"bibdata":{"bibtype":"article","type":"article","title":"Upfront Allogeneic Stem Cell Transplantation after Reduced-Intensity/Nonmyeloablative Conditioning for Patients with Myelodysplastic Syndrome: A Study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire","volume":"20","issn":"1083-8791","url":"http://www.ncbi.nlm.nih.gov/pubmed/24838178","doi":"10.1016/j.bbmt.2014.05.010","language":"English","journal":"Biol. Blood Marrow Transplant.","author":[{"firstnames":[],"propositions":[],"lastnames":["Damaj G"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Mohty M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Robin M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Michallet M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Chevallier P"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Beguin Y"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Nguyen S"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Bodes P"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Blaise D"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Maillard N"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Rubio MT"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Fegueux N"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Cornillon J"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Clavert A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Huynh A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Ades L"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Thiebaut-Bertrand A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Hermine O"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Vigouroux S"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Fenaux P"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Duhamel A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Yakoub-Agha I"],"suffixes":[]}],"year":"2014","keywords":"Adult, Aged, Antimetabolites, Antineoplastic/therapeutic use*, Azacitidine/therapeutic use*, Female, Hematopoietic Stem Cell Transplantation/methods*, Humans, Male, Middle Aged, Myelodysplastic Syndromes/mortality, Myelodysplastic Syndromes/therapy*, Transplantation Conditioning/methods*, Transplantation, Homologous/methods*, Young Adult","pages":"1349-1355","bibtex":"@article{damaj_g_upfront_2014,\r\ntitle = {Upfront Allogeneic Stem Cell Transplantation after Reduced-Intensity/Nonmyeloablative Conditioning for Patients with Myelodysplastic Syndrome: A Study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire},\r\nvolume = {20},\r\nissn = {1083-8791},\r\nurl = {http://www.ncbi.nlm.nih.gov/pubmed/24838178},\r\nDOI = {10.1016/j.bbmt.2014.05.010},\r\nLanguage = {English},\r\nJournal = {Biol. Blood Marrow Transplant.},\r\nauthor = {{Damaj G} and {Mohty M} and {Robin M} and {Michallet M} and {Chevallier P} and {Beguin Y} and {Nguyen S} and {Bodes P} and {Blaise D} and {Maillard N} and {Rubio MT} and {Fegueux N} and {Cornillon J} and {Clavert A} and {Huynh A} and {Ades L} and {Thiebaut-Bertrand A} and {Hermine O} and {Vigouroux S} and {Fenaux P} and {Duhamel A} and {Yakoub-Agha I}},\r\nyear = {2014},\r\nkeywords = {Adult, Aged, Antimetabolites, Antineoplastic/therapeutic use*, Azacitidine/therapeutic use*, Female, Hematopoietic Stem Cell Transplantation/methods*, Humans, Male, Middle Aged, Myelodysplastic Syndromes/mortality, Myelodysplastic Syndromes/therapy*, Transplantation Conditioning/methods*, Transplantation, Homologous/methods*, Young Adult},\r\npages = {1349-1355}\r\n}\r\n\r\n","author_short":["Damaj G","Mohty M","Robin M","Michallet M","Chevallier P","Beguin Y","Nguyen S","Bodes P","Blaise D","Maillard N","Rubio MT","Fegueux N","Cornillon J","Clavert A","Huynh A","Ades L","Thiebaut-Bertrand A","Hermine O","Vigouroux S","Fenaux P","Duhamel A","Yakoub-Agha I"],"key":"damaj_g_upfront_2014","id":"damaj_g_upfront_2014","bibbaseid":"damajg-mohtym-robinm-michalletm-chevallierp-beguiny-nguyens-bodesp-etal-upfrontallogeneicstemcelltransplantationafterreducedintensitynonmyeloablativeconditioningforpatientswithmyelodysplasticsyndromeastudybythesocietefrancaisedegreffedemoelleetdetherapiecellulaire-2014","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pubmed/24838178"},"keyword":["Adult","Aged","Antimetabolites","Antineoplastic/therapeutic use*","Azacitidine/therapeutic use*","Female","Hematopoietic Stem Cell Transplantation/methods*","Humans","Male","Middle Aged","Myelodysplastic Syndromes/mortality","Myelodysplastic Syndromes/therapy*","Transplantation Conditioning/methods*","Transplantation","Homologous/methods*","Young Adult"],"downloads":0},"bibtype":"article","biburl":"https://pro.univ-lille.fr/fileadmin/user_upload/pages_pros/patrick_devos/duhamel.bib","creationDate":"2019-06-21T09:30:55.038Z","downloads":0,"keywords":["adult","aged","antimetabolites","antineoplastic/therapeutic use*","azacitidine/therapeutic use*","female","hematopoietic stem cell transplantation/methods*","humans","male","middle aged","myelodysplastic syndromes/mortality","myelodysplastic syndromes/therapy*","transplantation conditioning/methods*","transplantation","homologous/methods*","young adult"],"search_terms":["upfront","allogeneic","stem","cell","transplantation","reduced","intensity","nonmyeloablative","conditioning","patients","myelodysplastic","syndrome","study","societe","francaise","greffe","moelle","therapie","cellulaire","damaj g","mohty m","robin m","michallet m","chevallier p","beguin y","nguyen s","bodes p","blaise d","maillard n","rubio mt","fegueux n","cornillon j","clavert a","huynh a","ades l","thiebaut-bertrand a","hermine o","vigouroux s","fenaux p","duhamel a","yakoub-agha i"],"title":"Upfront Allogeneic Stem Cell Transplantation after Reduced-Intensity/Nonmyeloablative Conditioning for Patients with Myelodysplastic Syndrome: A Study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire","year":2014,"dataSources":["Tt6zYqvN5kE3wbwiR"]}